Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma

by Mark A. Dickson, David R. D’Adamo, Mary L. Keohan, Sandra P. D’Angelo, Richard D. Carvajal, Mrinal M. Gounder, Robert G. Maki, Li-Xuan Qin, Robert A. Lefkowitz, Olivia R. McKennon, Catherine M. Hirst, Gary K. Schwartz, William D. Tap
Published 2015-01-01